Ralph Lauren Exceeds Expectations with Strong Q2 Results and Dividend Hike

Published 1 hours agoRL

Ralph Lauren Exceeds Expectations with Strong Q2 Results and Dividend Hike

Ralph Lauren Corporation has reported impressive financial outcomes for its fiscal second quarter, significantly surpassing analysts' forecasts. The company posted an adjusted earnings per share (EPS) of $2.10, beating the Zacks Consensus Estimate of $1.92. Additionally, net revenues showed a healthy year-over-year increase of 3%, totaling $1.633 billion and surpassing expectations of $1.609 billion.

In addition to these positive earnings, Ralph Lauren announced an increase in its quarterly cash dividend from $0.75 to $0.825 per share. The company also demonstrated robust operating performance, with its adjusted operating margin improving by 230 basis points to 18.7% and operating profit climbing by 27%. Global performance was strong as well, with notable revenue growth in Asia and Europe, where sales surged by 15% and 16%, respectively. The direct-to-consumer segment also saw remarkable expansion, adding 1.9 million new consumers.

These results reflect Ralph Lauren's strategic initiatives aimed at strengthening its financial position while responding to broader economic challenges. Reuters highlighted that the dividend increase underscores the company's commitment to maximizing shareholder value.

Share this article

Twitter Facebook LinkedIn

Recent Articles

No Current Confirmation on Morgan Stanley's Sale of Seven Seas Stake

No Current Confirmation on Morgan Stanley's Sale of Seven Seas Stake

3 minutes agoMS

Despite speculation, as of May 22, 2025, there is no confirmation that Morgan Stanley is selling its stake in Seven Seas Water to the EQT fund. The most recent transaction involving Seven Seas Water was in March 2020 when Morgan Stanley Infrastructure Partners acquired the company. Morgan Stanley Infrastructure Partners specializes in investing in crucial infrastructure services, and Seven Seas Water, based in Tampa, Florida, is known for its Water-as-a-Service (WaaS) solutions. This includes outsourced water treatment and wastewater treatment and reuse services provided to a variety of clients. Various sources, such as Business Wire, have detailed these aspects in past reports. The acquisition strategy by Morgan Stanley highlights their focus on assets that deliver essential public services, which aligns with Seven Seas Water’s role in providing vital water solutions. This transaction remains a significant development as rumors about further sales or changes in ownership are not substantiated by newly available public data.

AT&T to Acquire Lumen Technologies' Consumer Fiber Operations for $5.75 Billion

AT&T to Acquire Lumen Technologies' Consumer Fiber Operations for $5.75 Billion

18 minutes agoT

AT&T is set to acquire Lumen Technologies' consumer fiber operations in a $5.75 billion cash deal. This acquisition will add about 1 million fiber internet customers to AT&T's portfolio and expand its fiber network in major U.S. cities such as Denver, Las Vegas, and Seattle. The purchase aims to strengthen AT&T's foothold in the competitive U.S. fiber internet market. Lumen Technologies plans to leverage the proceeds from the sale to significantly reduce its debt by $4.8 billion. This strategic financial recalibration is anticipated to lower Lumen's annual interest expenses by over $300 million, providing the company with greater flexibility to concentrate on its enterprise fiber and low-latency technology sectors that are vital for modern tech applications like AI and multi-cloud systems. The transaction is expected to be finalized in the first half of 2026. Upon completion, the acquired assets will be organized under a new subsidiary, with AT&T planning to sell a minority stake in it. Following the transaction announcement, Lumen's shares jumped by 13% in after-market trading, signaling positive investor reception to the deal, as reported by Reuters.

Affirm and KAYAK's Partnership Remains U.S.-Exclusive

Affirm and KAYAK's Partnership Remains U.S.-Exclusive

33 minutes agoAFRM

As of May 22, 2025, the partnership between Affirm and KAYAK remains distinctly American. Originally formed in January 2023, this alliance identified Affirm as the exclusive pay-over-time provider for KAYAK within the United States. The union aimed to give travelers more flexible payment options when booking trips through KAYAK. In different territories, Affirm has been expanding its reach with various partners. Notably, in June 2024, Affirm teamed up with Alterra Mountain Company in Canada, marking a significant step in their Canadian collaborations. However, there's no clear indication that Affirm and KAYAK have looked north to expand their exclusive arrangement. Despite the broader growth of Affirm in regions such as Canada, the extension of its partnership with KAYAK remains confined to the U.S. landscape. These developments underscore Affirm's strategy to selectively grow its collaborative network, as information from Reuters suggests their focus may still be aligned with the initial terms of engagement with KAYAK.

UnitedHealthcare Under Scrutiny Amid Leadership Shakeup

UnitedHealthcare Under Scrutiny Amid Leadership Shakeup

48 minutes agoUNH

UnitedHealthcare, the largest insurance provider in the United States, is facing significant pressure following a series of troubling developments. The U.S. Department of Justice has launched a criminal investigation into the company's Medicare practices, specifically targeting the billing practices of its Medicare Advantage unit. This investigation comes on the heels of UnitedHealthcare's unexpected decision to withdraw its financial outlook and the sudden departure of CEO Andrew Witty, as Reuters reported. These issues have sparked a sharp decline in UnitedHealth's stock value, with shares plummeting 14% in a single day and suffering a 46% drop year-to-date. This stark decrease has brought the company's stock to a nearly five-year low, adding fuel to investor concerns about the company's trajectory amid these challenges. Adding to the company's troubles is its high rate of claim denials, where one in three claims is dismissed—twice the industry average. The Department of Justice is also scrutinizing UnitedHealth's proposed $3.3 billion purchase of Amedisys Inc., raising antitrust concerns. Meanwhile, the tragic shooting death of CEO Brian Thompson has resulted in further political and public scrutiny, especially following revelations that the ammunition used was labeled with references tied to the insurer's controversial practices.